Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersimmon Regulatory News (PSN)

Share Price Information for Persimmon (PSN)

Share Price is delayed by 15 minutes
Get Live Data
1,078.50    26.00 (2.47%)
Bid:
1,071.00
Ask:
1,072.00
Spread: 1.00 (0.093%)
Market Cap: £3.46b
PSN Live PriceLast checked at - London Stock Exchange

Intraday Persimmon Share Chart

Trading Update

15 Jan 2019 07:00

RNS Number : 0612N
Persimmon PLC
15 January 2019
 

TRADING UPDATE - 15 JANUARY 2019

 

Persimmon plc announces the following update ahead of its Final Results for the year ended 31 December 2018, which will be released on 26 February 2019.

 

Persimmon has delivered another strong trading performance, with continued disciplined growth in 2018 in line with the Group's strategy. Total Group revenues of £3.74bn were 4% higher than the prior year (2017: £3.60bn). New housing revenues increased by 4% to £3.55bn (2017: £3.42bn). Legal completion volumes increased by 406 new homes, a 3% increase, to 16,449 (2017: 16,043), including private sales of 13,341 new homes (2017: 13,274). Our average selling price of c. £215,560 was 1% higher than last year (2017: £213,321). The UK housing market has continued to benefit from robust employment levels, low interest rates and a competitive mortgage market, which have supported confidence and customer demand across the regions.

 

Persimmon remains committed to increasing new home construction to meet market demand and has made a significant contribution to increasing UK housing supply since the launch of the Group's new strategy in 2012. Over this period we have opened 1,370 new selling outlets and delivered 97,175 new homes to the market, increasing our annual production by over 75%. The Group now has 31 house building businesses across the UK, having opened seven new businesses over the last four years. The Group opened a new operating business based near Ipswich in Suffolk on 2 January 2018 which has made good progress, delivering 348 new homes in 2018. Additionally, on 2 January 2019, we opened a new business based at Harworth, near Doncaster, which will support our growth across the Yorkshire region. The Group is seeking to identify similar regional expansion opportunities and will continue to invest in both its infrastructure and people to support further growth.

 

The Group has a strong platform as we move into the new year. The value of the Group's forward sales at 31 December 2018 of c. £1,395m was 3% ahead of the prior year (2017: £1,356m) after second half legal completion volumes of 8,377, which were 305 stronger than for the first half of the year (H1: 8,072), an increase of 4%. The Group is currently building new homes on c. 365 active developments, a similar number to the same point last year, offering a good range and choice of family homes for first time buyers and home movers. We will be adding to our outlet network with the launch of a variety of high quality new sites over the coming weeks and are looking forward to the new spring season with a robust development pipeline. The c. 55 sites that we plan to open through the first quarter of the year include 15 outlets where we have been progressing build programmes to a more advanced stage to support improved availability and moving in dates for our customers.

We have continued with a selective approach to land replacement in line with our strategic priorities, being mindful of market cycle risks and wider economic uncertainties, including those associated with the process of the UK leaving the EU. The Group acquired over 17,000 plots of new land in over 80 locations through the year, with anticipated margins which continue to meet our targets.

 

The Group's cash generation remains strong. Cash balances of c. £1,048m were held at 31 December 2018 (2017: £1,303m) after returning £732m of capital to shareholders in 2018 (2017: £417m).

 

We anticipate our pre-tax profits for 2018 will be modestly ahead of current market consensus, having benefitted from the new developments we have opened through the year.

 

The Group continues to develop its manufacturing capabilities with the aim of better supporting sustainable growth. Brickworks, our new brick manufacturing plant located at Harworth, near Doncaster, is now nearing optimal production levels. The construction of the Group's new roof tile manufacturing plant, Tileworks, is progressing well on the same site. We look forward to Tileworks commencing deliveries to the business in the second half of 2019. In addition, Space4, the Group's manufacturing facility for our insulated frame build-system, based near Birmingham, continues to make a valuable contribution to the Group's output.

 

As we look forward to the 2019 spring season Persimmon is in an excellent market position. Whilst the future performance of the UK economy is currently subject to increased levels of uncertainty the Group is well positioned with its strong outlet network together with the availability of a range of attractive house types at affordable prices across the regions of the UK, supported by a high quality land bank and conservative financial structure. We will give an update on our assessment of the housing market over the early weeks of 2019 when we announce our results for the year ended 31 December 2018 on Tuesday 26 February 2019.

 

 

Please Note

There will be a call for analysts at 09.00 GMT today. Please use the dial-in details below:

Telephone number

:

+44 (0)33 3300 0804

Access pin

:

47240467#

Passcode

:

Persimmon

 

An audiocast of the call will be available on www.persimmonhomes.com/corporate

 

For further information please contact:

 

Dave Jenkinson, Interim Group Chief Executive

Simon Rigby

Mike Killoran, Group Finance Director

Kevin Smith

Jos Bieneman

Persimmon plc

Citigate Dewe Rogerson

Tel: +44 (0) 1904 642199

Tel: +44 (0) 20 7638 9571

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGMGMMNDLGLZM
Date   Source Headline
1st May 20257:00 amRNSAGM Trading Statement
25th Apr 202510:54 amRNSHolding(s) in Company
25th Apr 20259:24 amRNSHolding(s) in Company
11th Apr 20254:22 pmRNSHolding(s) in Company
3rd Apr 202510:15 amRNSHolding(s) in Company
2nd Apr 202512:22 pmRNSHolding(s) in Company
1st Apr 202512:03 pmRNSTotal Voting Rights
31st Mar 20253:14 pmRNSDirector/PDMR Shareholding
27th Mar 202510:08 amRNSHolding(s) in Company
25th Mar 20253:14 pmRNSDirector/PDMR Shareholding
24th Mar 20253:35 pmRNSAnnual Report 2024 and Notice of AGM 2025
24th Mar 20252:24 pmRNSHolding(s) in Company
11th Mar 20257:00 amRNSFull Year Results
6th Mar 20252:06 pmRNSHolding(s) in Company
3rd Mar 20253:35 pmRNSHolding(s) in Company
3rd Feb 202512:26 pmRNSTotal Voting Rights
14th Jan 20257:00 amRNS2024 Trading Statement
2nd Jan 20251:00 pmRNSTotal Voting Rights
10th Dec 20243:47 pmRNSDirectorate Change
2nd Dec 20242:11 pmRNSBlock listing Interim Review
2nd Dec 202412:00 pmRNSTotal Voting Rights
6th Nov 20247:00 amRNSQ3 Trading Statement
5th Nov 20241:31 pmRNSHolding(s) in Company
1st Nov 20243:59 pmRNSTotal Voting Rights
1st Oct 20241:19 pmRNSTotal Voting Rights
24th Sep 202412:25 pmRNSDirector/PDMR Shareholding
2nd Sep 20241:44 pmRNSTotal Voting Rights
8th Aug 20247:00 amRNSHalf Year Results
1st Aug 20242:32 pmRNSTotal Voting Rights
23rd Jul 202410:28 amRNSDirectorate Change
1st Jul 20241:10 pmRNSTotal Voting Rights
19th Jun 20242:48 pmRNSDirector/PDMR Shareholding
3rd Jun 202412:33 pmRNSBlock listing Interim Review
3rd Jun 202411:08 amRNSTotal Voting Rights
23rd May 20247:00 amRNSConfirmation of CFO start date
1st May 20241:11 pmRNSTotal Voting Rights
30th Apr 20242:03 pmRNSDirectorate Change
25th Apr 20242:09 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Statement
2nd Apr 20241:49 pmRNSTotal Voting Rights
28th Mar 202412:53 pmRNSDirector/PDMR Shareholding
25th Mar 20244:47 pmRNSDirector/PDMR Shareholding
25th Mar 20242:07 pmRNSAnnual Report 2023 and Notice of AGM 2024
12th Mar 20241:38 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSFull Year Results
11th Jan 20246:00 pmRNSDechra Pharmaceuticals
10th Jan 20247:00 amRNSTrading Statement
1st Dec 20234:48 pmRNSBlock listing Interim Review
1st Dec 20234:45 pmRNSTotal Voting Rights
17th Nov 202310:25 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.